Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial ribosomal 30S A-site is a region in the small (30S) subunit of the prokaryotic ribosome responsible for the initial selection and binding of aminoacyl-tRNA during translation. The A-site, located within the complex of 16S ribosomal RNA and associated proteins, ensures decoding accuracy by monitoring base pairing between the mRNA codon and the tRNA anticodon. Universal residues in 16S rRNA (such as A1492 and A1493) play critical roles in this process. The 30S A-site is a major target for several classes of antibiotics, notably aminoglycosides and spectinomycin, which bind to this region and disrupt normal translational fidelity, thereby inhibiting bacterial protein synthesis. Mutations in A-site constituents can confer resistance to these drugs, presenting a clinical challenge and motivating ongoing antibiotic development[1][2][3][4][5].
Interference with decoding by stabilizing erroneous tRNA–mRNA pairing. Disruption of translocation and fidelity mechanisms in protein synthesis. Binding to specific rRNA residues (notably 16S RNA nucleotides A1492, A1493, G530).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial ribosomal 30S A-site (30S A-site).